Your browser is no longer supported. Please, upgrade your browser.
ELOX Eloxx Pharmaceuticals, Inc. daily Stock Chart
Eloxx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.36 Insider Own0.10% Shs Outstand40.07M Perf Week0.60%
Market Cap137.61M Forward P/E- EPS next Y-0.85 Insider Trans0.00% Shs Float35.65M Perf Month15.57%
Income-52.90M PEG- EPS next Q-0.23 Inst Own52.60% Short Float3.98% Perf Quarter33.60%
Sales- P/S- EPS this Y8.10% Inst Trans0.09% Short Ratio10.25 Perf Half Y-19.90%
Book/sh0.66 P/B5.06 EPS next Y13.50% ROA-80.40% Target Price- Perf Year-49.24%
Cash/sh1.07 P/C3.13 EPS next 5Y- ROE-124.90% 52W Range1.44 - 8.16 Perf YTD-54.62%
Dividend- P/FCF- EPS past 5Y44.90% ROI- 52W High-59.08% Beta2.63
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low131.94% ATR0.24
Employees29 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)61.43 Volatility9.45% 7.51%
OptionableYes Debt/Eq0.54 EPS Q/Q-4.90% Profit Margin- Rel Volume1.44 Prev Close3.09
ShortableYes LT Debt/Eq0.36 EarningsAug 06 AMC Payout- Avg Volume138.57K Price3.34
Recom2.00 SMA2011.46% SMA508.59% SMA200-13.26% Volume199,188 Change8.09%
Jun-11-20Downgrade Citigroup Buy → Neutral
Sep-06-19Initiated Janney Buy $14
Dec-24-18Initiated H.C. Wainwright Neutral $10
Jul-03-18Initiated Citigroup Buy
Aug-12-20 07:30AM  
Aug-06-20 07:30AM  
Aug-04-20 07:30AM  
Jul-28-20 12:33PM  
Jul-21-20 02:17PM  
Jul-17-20 12:37PM  
Jul-15-20 01:08PM  
Jun-18-20 11:14AM  
Jun-17-20 04:01PM  
Jun-11-20 12:06PM  
May-27-20 12:48PM  
May-08-20 03:01PM  
May-07-20 04:01PM  
Apr-21-20 12:37PM  
Apr-20-20 09:24AM  
Apr-13-20 07:30AM  
Apr-06-20 10:53AM  
Mar-25-20 09:00AM  
Mar-10-20 01:45PM  
Mar-05-20 04:00PM  
Feb-26-20 04:00PM  
Jan-14-20 02:30PM  
Dec-27-19 06:38AM  
Dec-24-19 07:45AM  
Dec-22-19 06:41PM  
Dec-18-19 07:00AM  
Dec-11-19 05:09PM  
Dec-06-19 07:43AM  
Nov-19-19 07:00AM  
Nov-18-19 07:00AM  
Nov-07-19 10:00AM  
Nov-05-19 04:01PM  
Oct-31-19 12:15PM  
Oct-23-19 12:18PM  
Oct-10-19 08:41AM  
Sep-23-19 07:30AM  
Sep-16-19 07:30AM  
Sep-13-19 07:48PM  
Sep-10-19 07:30AM  
Aug-26-19 09:30AM  
Aug-13-19 10:01AM  
Aug-08-19 12:51PM  
Aug-07-19 07:30AM  
Aug-05-19 08:00AM  
Jul-31-19 12:12PM  
Jul-17-19 07:30AM  
Jun-24-19 04:01PM  
Jun-20-19 08:36AM  
Jun-19-19 04:01PM  
Jun-10-19 08:00AM  
Jun-06-19 04:27PM  
May-27-19 11:10AM  
May-21-19 12:50PM  
May-19-19 09:29PM  
May-09-19 02:50PM  
May-02-19 10:30AM  
Apr-22-19 09:37AM  
Apr-15-19 01:15PM  
Apr-11-19 02:45PM  
Mar-27-19 09:00AM  
Mar-26-19 12:11PM  
Mar-20-19 12:19PM  
Mar-12-19 11:35PM  
Mar-08-19 11:39AM  
Mar-05-19 09:08AM  
Feb-26-19 04:02PM  
Feb-20-19 04:00PM  
Feb-19-19 07:00AM  
Feb-14-19 08:40AM  
Feb-13-19 11:12AM  
Feb-04-19 07:00AM  
Jan-03-19 01:08PM  
Dec-20-18 02:54PM  
Dec-19-18 05:37AM  
Dec-17-18 08:39PM  
Nov-20-18 07:00AM  
Nov-19-18 07:00AM  
Nov-08-18 07:00AM  
Oct-18-18 11:49AM  
Oct-16-18 06:16PM  
Sep-24-18 07:00AM  
Aug-07-18 04:01PM  
Jul-18-18 07:30AM  
Jul-17-18 07:30AM  
Jun-25-18 04:20PM  
Jun-18-18 07:30AM  
Jun-11-18 07:30AM  
Jun-08-18 11:00AM  
May-10-18 04:01PM  
May-01-18 01:27PM  
Apr-30-18 04:01PM  
Apr-27-18 12:41PM  
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel ribonucleic acid for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which has completed Phase 1 clinical trial that focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams Gregory C.CHIEF EXECUTIVE OFFICERJul 30Option Exercise0.001,87508,083Jul 31 04:10 PM
Belloff Neil S.COO, GENERAL COUNSEL &CORP SECJul 30Option Exercise0.001,56306,750Jul 31 04:10 PM